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Background: Progressive hepatic fibrosis is the eventual cause of liver cirrhosis. Doppler ultrasound has been used
to detect hemodynamic changes that are known to be present during the pre-cirrhotic stages of hepatic
fibrogenesis. However, the relationship between the Doppler ultrasound parameters and the impairment of the
liver function has not been fully investigated. The purpose of this study was to explore the hepatic function reserve
and its relationship with the hepatic hemodynamics in a rabbit model of liver fibrosis using Doppler ultrasound.
Methods: A prospective study was performed. Sixty healthy New Zealand rabbits were included in this study.
Eleven of them served as controls and were normally fed and provided with water drink; the rest of 49 rabbits that
served as fibrosis group were normally fed but provided with 1.2 g/L of thioacetamide to create liver fibrosis model.
Doppler measurements were performed in the portal trunk, proper hepatic artery and proper splenic artery. The
hepatic circulation index (HCI) was calculated. Hepatic function reverse was evaluated by measuring the
indocyanine green clearance and retention rate at 15 min (ICG R15) test. Portal venous pressure (PVP) was
measured using the portal vein punctuation equipment.
Results: HCI was significantly decreased and PVP increased in the advanced fibrotic stage (F4) compared to mild
and moderate fibrotic stage (F1-3), respectively (p<0.05). PVP and ICG R15 in the fibrotic group were significantly
higher than that in the control group (ICG: 0.209±0.086 vs. 0.093±0.023, p<0.01). Within the fibrotic groups, PVP was
higher in advanced fibrotic stage (F4) than those in mild (F1-2) or moderate (F3) fibrotic stages (p<0.05). Both HCI
and PVP correlated well with ICG R15 (r = −0.890, and r = 0.780, p <0.01).
Conclusions: Hepatic function reserve closely relates to the hepatic hemodynamics in the rabbit model of liver
fibrosis. Doppler Ultrasound could be reliably used to assess the hepatic function reserve and hemodynamic
changes in different stages of liver fibrosis.
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Progressive hepatic fibrosis is the eventual cause of liver
cirrhosis. There is increasing evidence that, unlike cirrhosis,
fibrosis is treatable and reversible in its early stages. Prompt
and effective treatment could postpone or interrupt the
development of chronic hepatitis into liver cirrhosis [1-4].
Thus assessment of hepatic functional reserve in patients* Correspondence: yangyl@fmmu.edu.cn; duanyy@fmmu.edu.cn
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reproduction in any medium, provided the orwith fibrosis is critical for predicting its prognosis and
preventing postoperative liver failure.
Quantitative tests of hepatic function are thought to
assess the functional hepatic mass by measuring the
blood flow-dependent hepatocyte function, such as indo-
cyanine green (ICG) clearance. It is considered to reflect
the degree of sinusoidal capillarization, intrahepatic por-
tovenous shunt and alteration in liver blood flow [2,3].
Earlier studies indicated that ICG clearance was a good
marker of hepatocellular uptake function [4]. Altered ICG
clearance is an extremely sensitive early indicator of
hepatocyte abnormality [5]. Thus ICG clearance andd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Stage of liver fibrosis at different time intervals
F1 F2 F3 F4
8w 11 1 0 0
12w 0 4 6 2
16w 0 0 9 3
20w 0 0 3 10
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used to assess liver function reserve in patients with
chronic liver diseases, and to evaluate the liver function in
organ donors and recipients and in critically ill patients.
At present, the diagnosis of liver fibrosis still depends
on pathological examination of the liver tissue. Since this
method is invasive, its application and extensive use in
clinical practice are limited to diagnose and stage liver
diseases affecting large segments of the population or to
monitor disease progression or treatment effects [6].
Thus, greater attention has been paid to search for non-
invasive diagnostic parameters for assessing liver fibrosis.
Ultrasonography (US) is the first choice of imaging
modality used in the clinic in patients with diffuse liver
disease [7]. The use of gray and color Doppler US in
diagnosis and staging of chronic liver disease is based on
the hypothesis that alteration of liver parenchyma and
hemodynamics may reflect indirectly the histological
alterations. The combination of gray scale US and Doppler
US improve the diagnostic accuracy and are essential for
the diagnosis of cirrhosis or fibrosis [8,9]. Doppler US has
been used to detect hemodynamic changes that are known
to be present during the pre-cirrhotic stages of hepatic
fibrogenesis. However, though US Doppler parameters in
patients with hepatic fibrosis show differences when
compared to controls, the relationship between these
parameters and the impairment of the liver function has
not been fully investigated. In the present study, we
adopted an experimental New Zealand rabbit model of
liver fibrosis to observe the hemodynamic changes at
different stages of fibrosis by US, and to evaluate whether




All experimental animals were purchased from the Ani-
mal Experimentation Center of Academy of Traditional
Chinese Medicine, Shaan’xi, China. Sixty healthy New
Zealand rabbits, weighed 2.5~3.0 kg, were randomly en-
rolled into the study. Eleven for control group were
normally fed and provided with water drink, and 49 for
experimental group were normally fed but provided with
1.2 g/L of thioacetamide instead of water to set up ex-
perimental liver fibrosis model [10]. During the course
of 8th, 12th, and 16th week, twelve experimental rabbits
were picked out at random for examination, and the
remaining experimental rabbits were handled at the 20th
week. Stage of liver fibrosis at different time intervals
were presented in Table 1. Before the examination the
animals were fasted for 6 h but had free access to water.
Anesthesia was performed by intramuscular injection of
0.15 ml/kg of Sumianxin. The fur of hepatic region was
shaved with 8% of sodium sulfide.This study protocol complied with the guidelines for
animal care of our institution and European community
council directives. All procedures were reviewed and
approved by the Animal Ethics Committee of the Fourth
Military Medical University of the People’s Liberation
Army of China (Xi’an, China).
Doppler ultrasonography
Ultrasonography was performed using Sequoia 512
(Acuson Medical Ultrasonography Systems, USA) equipped
with a linear array high frequency probe (8-13 MHz). The
depth and instrument parameters remained unchanged
during the course of examination. The liver was examined
directly, and the superior mesenteric artery and splenic ar-
tery were detected using water-filled balloon method due to
smaller diameters. Doppler sample volume was positioned
in the center of the vessel and the sample width was
selected to cover almost entire vessel diameter. Pulse repe-
tition frequency was adjusted so as not to exceed the limit
of the displayed maximum velocity. Care was taken to
ensure that the angle of insonation was always smaller
than 60 degree. Internal diameter of the vessels was mea-
sured manually after optimizing B mode images. The
hemodynamic parameters such as the maximum, mini-
mum and mean blood flow velocity (Vmax, Vmin, Vm),
pulsatility index (PI) and resistance index (RI) were
obtained. The hepatic circulate index (HCI) at different
stages of liver fibrosis was calculated using the formula:
HCI = PPV×PHA/SPPI (PPV: portal venous peak velocity;
PHA: hepatic arterial peak velocity; SPPI: splenic arterial
pulsatility index) [11,12]. All data were saved in machine-
attached MO-CD for further analysis. The ultrasound oper-
ator was blinded with laboratory findings.
Indocyanine green test
ICG (0.5 mg/kg of body weight) was injected via a per-
ipheral vein. Serum was collected before and at 5, 10
and 15 minutes after the ICG injection to determine the
ICG retention rate at 15 minutes (ICG R15). Each sam-
ple was diluted to one fourth of the concentration with
saline, and the concentration of ICG in the specimens
was analyzed by spectrophotometer at wave length of
805 nm. The calibration curve was made by the use of
serum collected before the ICG injection in each rabbit











Diameter (mm) 3.68 ± 0.31 3.59 ± 0.30 3.63 ± 0.29 3.66 ± 0.25
Vm (cm/s) 14.3 ± 3.0 13.6 ± 3.5 13.4 ± 4.7 12.7 ± 3.2
FV (ml/min) 91 ± 8 82 ± 6 83 ± 6 80 ± 7
Hepatic artery
Diameter (mm) 1.04 ± 0.23 1.12 ± 0.31 1.02 ± 0.19 1.05 ± 0.20
Vm (cm/s) 12.5 ± 4.8 13.2 ± 5.8 12.9 ± 5.1 13.7 ± 5.5
Vmax (cm/s) 26.3 ± 5.2 25.8 ± 5.5 26.3 ± 6.3 28.8 ± 10.8
HCI 452 ± 47 396 ± 56 308 ± 44 243 ± 55
Notes: Vm: Mean flow velocity; FV: Flow volume; Vmax: Peak systolic velocity;
HCI: Hepatic circulation index.
Figure 1 HCI in different stages of fibrosis. F0, without fibrosis;
F1-2, mild fibrosis stage 1–2; F3, moderate fibrosis stage 3; and F4,
advanced fibrosis stage 4.
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10 percentages at 15 min is considered to be within
normal limits.
Conventional liver function tests
The serum total bilirubin (T.B), albumin (ALB),alanine
aminotransferase (ALT) and prothrombin time (PT)
of the experimental animals were determined after
ultrasound examination.
Measurement of portal venous pressure
Portal venous pressure (PVP) was measured by a portal
vein punctuation equipment.
Histology examination
After examination, rabbits were sacrificed and liver
specimens were fixed in formalin and embedded in par-
affin. The slides stained by hematoxylin eosin (HE) and
Masson three colors were evaluated by two independent
expert pathologists. Liver fibrosis was evaluated accord-
ing to the Xi’an meeting scoring system [13]. Fibrosis
was staged as follows: no fibrosis (F0); F1- portal fibrosis
without septa; F2- portal fibrosis and few septa; F3- nu-
merous septa without cirrhosis; F4- cirrhosis. We found
no significant difference in hemodynamics between stage
F1 and F2 (data not shown), we thus combined these
two stages as one. Thus, animals were divided into four
groups: mild (F1-2), moderate (F3), advanced (F4) and
control (F0) group according to fibrosis degree.
Statistical analysis
The fibrosis stages were identified according to patho-
logic findings. Statistical analyses were carried out with
SPSS 10.0 software (SPSS Inc., Chicago, IL, USA). All
variables were expressed as the mean values ± standard
deviation (mean±SD). A statistical analysis for continu-
ous variable was performed using a student’s t test. For
multiple values, ANOVA (analysis of variance) with LSD
(least square design) was used. The agreement between
the two measurements from two independent patholo-
gists and between the two measurements from one path-
ologist at different time was performed. P value less than
0.05 was considered to represent statistically significant
difference between tested data sets.
Results
Hepatic hemodynamics by ultrasound and correlation
with the ICG R15
The results of the ultrasound Doppler studies were sum-
marized in Table 2. Portal venous velocity was not sig-
nificantly different between groups. In contrast, HCI was
significantly decreased in the advanced fibrotic stage
(F4) compared to the mild (F1-2) and moderate fibrotic
stages (F3), respectively (p<0.05). HCI was alsosignificantly lower in F3 than that in F1-2 and F0 groups
(p<0.05) (Figure1).
The ICG R15 in the fibrotic groups was significantly
higher than that in the control group (0.209±0.086 vs.
0.093±0.023, p<0.01) (Figure 1). ICG R15 was higher in
the advanced fibrotic stage (F4) than that in the mild
(F1-2) or moderate (F3) fibrotic stage: 0.294±0.058 vs.
0.114±0.022 and 0.225±0.051, respectively (p<0.01)
(Figure 2). A better inverse correlation was found between
HCI and ICG R15 (r = −0.890, p <0.01) (Figure 3).
Correlation of hepatic hemodynamics with PVP and
liver function
Conventional liver function parameters of different
degree of liver fibrosis were shown in Table 3. The
difference of ALT between experimental groups and
control group was significant (p<0.01). The results of
PVP studies are depicted in Figure 4. The mean PVP
Figure 2 ICG retention rate (percentage of total injected ICG dose) at 15 min (ICG 15) in different stages of fibrosis. F0, without fibrosis;
F1-2, mild fibrosis stage 1–2; F3, moderate fibrosis stage 3; and F4, advanced fibrosis stage 4.
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that in the control group. PVP was higher in advanced
fibrotic stage (F4) than those in mild (F1-2) or moderate
(F3) fibrotic stage: 1.03±0.12 kPa vs. 0.74±0.06 kPa and
0.82±0.08 kPa, respectively (p<0.05) (Figure 4).With the
development of fibrosis, PVP tended to increase and
serum ALB decreased. A better correlation was found
between PVP and HCI (r = 0.734, p<0.01) (Figure 5).
On the other hand, there was no significant correlation
between HCI and serum total bilirubin (r=0.109,
p=0.407), serum albumin (p=0.165, r =0.181) and alanine
aminotransferase (r =0.012, p=−0.437) (Figure 6 A-C).Figure 3 Correlation between HCI (Hepatic circulation index)
and ICG retention rate (percentage of total injected ICG dose)
at 15 min in different stages of fibrosis.Inter and intra-observer variability
The agreement of staging the fibrosis was 94% for the
two independent expert histopathologists and 100% for
one of the expert histopathologists.
Discussion
The present study demonstrated that Doppler para-
meters could identify different stages of hepatic fibrosis,
and these Doppler parameters correlated closely with
ICG retention rate (percentage of total injected ICG
dose) at 15 min (ICG 15), which is considered to be one
of the most valuable and reliable tests for assessing hep-
atic functional reserve and predicting post-hepatectomy
liver failure in cirrhotic patients.
The assessment of hepatic functional reserve of
patients with cirrhosis is critical for predicting prognosis,
postoperative outcome in those who are candidates for
nonhepatic surgery or liver resection for hepato-cellular
carcinoma (HCC), or for determining the timing of liver
transplantation in patients with advanced cirrhosis [14].
Quantitative assessment of hepatic function reserve be-









ALT(U/L) 36±15 156±52 168±49 152±40
ALB(g/L) 37.3±5.7 37.2±3.7 36.8±2.6 35.6±3.4
T.B(umol/L) 8.6±2.4 8.5±3.3 9.2±3.6 8.2±4.7
PT(s) 11.5±1.3 10.1±1.5 11.9±0.9 10.7±1.8
ALT: Alanine aminotransferase; ALB: Albumin; T.B: Total bilirubin; PT,
prothrombin.
Figure 4 PVP (Portal venous pressure) at the different stages of
fibrosis in four sub-groups. F0 (without fibrosis), F1-2 (mild fibrosis
stage 1–2), F3 (moderate fibrosis stage 3) and F4 (advanced fibrosis
stage 4).
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liver biopsy is the gold standard for diagnosing and sta-
ging liver fibrosis, its clinical application is limited be-
cause of its invasiveness. Exploring non-invasive
methods for evaluating hepatic reserve function of liver
fibrosis is of significance. Present study showed that
ALT concentration was increased significantly after mod-
eling, and remained at a high lever during the fibrosis
stage. However, no significant difference in ALT was
found between all experimental groups, indicating that
the conventional hepatic function parameters are not
sensitive in reflecting the hepatic reserve function
changes at different stages of liver fibrosis. ICG retention
rate at 15 min (ICG R15) is considered to be one of the
most valuable and reliable tests for assessing hepaticFigure 5 Correlation between PVP (Portal venous pressure) and
HCI (Hepatic circulation index) at different stages of fibrosis.
Figure 6 Correlation between HCI (Hepatic circulation index)
and liver function in fibrotic group. A: serum albumin (ALB); B:
serum total bilirubin (T.B); C: alanine aminotransferase (ALT).functional reserve and predicting post-hepatectomy liver
failure in cirrhotic patients. The present study also
showed that with the development of liver damage, ICG
R15 was increased while clearance ratio of indocyanine
green decreased, and there was significant difference in
ICG R15 among experimental groups. This might be
related to the fact that the liver blood flow resistance
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atic sinusoidal endothelium capillarization, resulting in
the decreased effective hepatic flow volume. These
results suggest that ICGR15 could better reflect the se-
verity of the liver fibrosis compared to the conventional
hepatic function parameters.
Though ICG R15 is considered to be one of the most
valuable and reliable tests for assessing hepatic func-
tional reserve and predicting post-hepatectomy liver fail-
ure in cirrhotic patients, the measurement of ICG R15 is
relatively complicated. The liver fibrosis is a pathological
process of abnormal proliferation of hepatic fiber con-
nective tissue in response to various kinds of liver-
damaging factors, which is mainly characterized by the
excessive deposition of extracellular matrix and hepatic
sinusoidal endothelium capillarization. Advanced liver
fibrosis results in the change of hepatic vascular struc-
ture and the increase of the hepatic vascular resistance,
and even develops into portal hypertension. Actually in
human, there is development of portal hypertension
even in pre-cirrhotic stage. After development in portal
hypertension, there are changes in the hepatic circula-
tion. Thus, the hepatic hemodynamic parameters by US
might change with the development of liver fibrosis.
Although there was no significant difference in blood
flow velocity of hepatic artery and portal venous system
between the experimental group and the control group,
HCI, a parameter that combines both the hepatic arterial
and portal venous measurement, was decreased gradually
with the development of fibrosis. Moreover, HCI has sig-
nificant negative correlation with portal venous pressure
and ICG R15, indicating that the liver and its peripheral
organs were in high-resistance state since HCI could over-
all reflect the liver blood flow perfusion profile that corre-
lated with hepatic reserve function [11]. These results
indicate that HCImight be an alternative parameter of
ICG R15 that could sensitively reflect the gradually-
decreased hepatic reserve function during the course of
different degree of liver fibrosis and portal hypertension.
Conclusions
In conclusion, hepatic function reserve closely relates to
the hepatic hemodynamics in the rabbit model of liver
fibrosis. Doppler Ultrasound could be reliably used to
assess the hepatic function reserve and hemodynamic
changes at different stages of liver fibrosis.
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